BARBARA HORSEY O'CONNOR,SHAUN E. BUCKLEY,DAVID J. BURKE,SHERWOOD RUSS LEHRMAN
申请号:
BRPI0812561
公开号:
BRPI0812561A2
申请日:
2008.06.13
申请国别(地区):
BR
年份:
2014
代理人:
摘要:
The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the recombinant humanized anti-alpha-4 integrin antibody natalizumab.